Journal of Neuroimmunology
Volume 211, Issue 1 , Pages 39-48 , 25 June 2009

Prenatal exposure to antibodies from mothers of children with autism produces neurobehavioral alterations: A pregnant dam mouse model

  • Harvey S. Singer

      Affiliations

    • Departments of Neurology, Johns Hopkins University School of Medicine, Baltimore, MD, United States
    • Corresponding Author InformationCorresponding author. Johns Hopkins Hospital, Rubenstein Child Health Building, 200 N. Wolfe Street, Suite 2158, Baltimore, MD 21287, United States. Tel.: +1 410 955 7212; fax: +1 410 614 2297.
  • ,
  • Christina Morris

      Affiliations

    • Departments of Neurology, Johns Hopkins University School of Medicine, Baltimore, MD, United States
  • ,
  • Colin Gause

      Affiliations

    • Departments of Neurology, Johns Hopkins University School of Medicine, Baltimore, MD, United States
  • ,
  • Matthew Pollard

      Affiliations

    • Departments of Neurology, Johns Hopkins University School of Medicine, Baltimore, MD, United States
  • ,
  • Andrew W. Zimmerman

      Affiliations

    • Departments of Neurology, Johns Hopkins University School of Medicine, Baltimore, MD, United States
    • Kennedy Krieger Institute, Baltimore, MD, United States
  • ,
  • Mikhail Pletnikov

      Affiliations

    • Departments of Psychiatry and Behavioral Sciences, Johns Hopkins University School of Medicine, Baltimore, MD, United States

Received 13 November 2008 ,Revised 9 March 2009 ,Accepted 9 March 2009.

References 

  1. Andres C. Molecular genetics and animal models in autistic disorder. Brain Res. Bull. 2002;57:109–119
  2. Archelos JJ, Hartung HP. Pathogenetic role of autoantibodies in neurological diseases. Trends Neurosci. 2000;23:317–327
  3. Ashdown H, Dumont Y, Ng M, Poole S, Boksa P, Luheshi GN. The role of cytokines in mediating effects of prenatal infection on the fetus: implications for schizophrenia. Mol. Psychiatry. 2006;11:47–55
  4. American Psychiatric Association . Diagnostic and statistical manual of mental disorders: DSM-IV. Washington, D.C.: American Psychiatric Association; 1994;
  5. Braunschweig D, Ashwood P, Krakowiak P, Hertz-Picciotto I, Hansen R, Croen LA, et al. Autism: maternally derived antibodies specific for fetal brain proteins. Neurotoxicology. 2008;29:226–231
  6. Chen L, Toth M. Fragile X mice develop sensory hyperreactivity to auditory stimuli. Neuroscience. 2001;103:1043–1050
  7. Comi AM, Zimmerman AW, Frye VH, Law PA, Peeden JN. Familial clustering of autoimmune disorders and evaluation of medical risk factors in autism. J. Child Neurol. 1999;14:388–394
  8. Connolly AM, Chez M, Streif EM, Keeling RM, Golumbek PT, Kwon JM, et al. Brain-derived neurotrophic factor and autoantibodies to neural antigens in sera of children with autistic spectrum disorders, Landau–Kleffner syndrome, and epilepsy. Biol. Psychiatry. 2006;59:354–363
  9. Crawley JN. Behavioral phenotyping of transgenic and knockout mice: experimental design and evaluation of general health, sensory functions, motor abilities, and specific behavioral tests. Brain Res. 1999;835:18–26
  10. Crawley JN. Mouse behavioral assays relevant to the symptoms of autism. Brain Pathol. 2007;17:448–459
  11. Croen LA, Braunschweig D, Haapanen L, Yoshida CK, Fireman B, Grether JK, et al. Maternal mid-pregnancy autoantibodies to fetal brain protein: the early markers for autism study. Biol. Psychiatry. 2008;64:583–588
  12. Cruz AP, Frei F, Graeff FG. Ethopharmacological analysis of rat behavior on the elevated plus-maze. Pharmacol. Biochem. Behav. 1994;49:171–176
  13. Dalton P, Deacon R, Blamire A, Pike M, McKinlay I, Stein J, et al. Maternal neuronal antibodies associated with autism and a language disorder. Ann. Neurol. 2003;53:533–537
  14. Dierssen M, Fotaki V, Martinez de Lagran M, Gratacos M, Arbones M, Fillat C, et al. Neurobehavioral development of two mouse lines commonly used in transgenic studies. Pharmacol. Biochem. Behav. 2002;73:19–25
  15. Djalali S, Holtje M, Grosse G, Rothe T, Stroh T, Grosse J, et al. Effects of brain-derived neurotrophic factor (BDNF) on glial cells and serotonergic neurones during development. J. Neurochem. 2005;92:616–627
  16. Eikelis N, Van Den Buuse M. Cardiovascular responses to open-field stress in rats: sex differences and effects of gonadal hormones. Stress. 2000;3:319–334
  17. Gayle DA, Beloosesky R, Desai M, Amidi F, Nunez SE, Ross MG. Maternal LPS induces cytokines in the amniotic fluid and corticotropin releasing hormone in the fetal rat brain. Am. J. Physiol., Regul. Integr. Comp. Physiol. 2004;286:R1024–1029
  18. Golan HM, Lev V, Hallak M, Sorokin Y, Huleihel M. Specific neurodevelopmental damage in mice offspring following maternal inflammation during pregnancy. Neuropharmacology. 2005;48:903–917
  19. Grider MH, Mamounas LA, Le W, Shine HD. In situ expression of brain-derived neurotrophic factor or neurotrophin-3 promotes sprouting of cortical serotonergic axons following a neurotoxic lesion. J. Neurosci. Res. 2005;82:404–412
  20. Karl T, Pabst R, von Horsten S. Behavioral phenotyping of mice in pharmacological and toxicological research. Exp. Toxicol. Pathol. 2003;55:69–83
  21. Lang PJ, Bradley M, Cuthbert BN. Emotion, attention, and the startle reflex. Psychol. Rev. 1990;97:377–395
  22. Locksley RM, Killeen N, Lenardo MJ. The TNF and TNF receptor superfamilies: integrating mammalian biology. Cell. 2001;104:487–501
  23. Lord C, Risi S, Lambrecht L, Cook EHJ, Leventhal BL, DiLavore PC, et al. The autism diagnostic observation schedule — generic: a standard measure of social and communication deficits associated with the spectrum of autism. J. Autism Dev. Disord. 2000;30:205–223
  24. Mamounas LA, Blue ME, Siuciak JA, Altar CA. Brain-derived neurotrophic factor promotes the survival and sprouting of serotonergic axons in rat brain. J. Neurosci. 1995;15:7929–7939
  25. Martin LA, Ashwood P, Braunschweig D, Cabanlit M, Van de Water J, Amaral DG. Stereotypies and hyperactivity in rhesus monkeys exposed to IgG from mothers of children with autism. Brain Behav. Immun. 2008;22:806–816
  26. Meyer U, Nyffeler M, Engler A, Urwyler A, Schedlowski M, Knuesel I, et al. The time of prenatal immune challenge determines the specificity of inflammation-mediated brain and behavioral pathology. J. Neurosci. 2006;26:4752–4762
  27. Moretti P, Bouwknecht JA, Teague R, Paylor R, Zoghbi HY. Abnormalities of social interactions and home-cage behavior in a mouse model of Rett syndrome. Hum. Mol. Genet. 2005;14:205–220
  28. Moy SS, Nadler JJ, Young NB, Perez A, Holloway LP, Barbaro RP, et al. Mouse behavioral tasks relevant to autism: phenotypes of 10 inbred strains. Behav. Brain Res. 2007;176:4–20
  29. Nelson KB, Grether JK, Croen LA, Dambrosia JM, Dickens BF, Jelliffe LL, et al. Neuropeptides and neurotrophins in neonatal blood of children with autism or mental retardation. Ann. Neurol. 2001;49:597–606
  30. Ozawa K, Hashimoto K, Kishimoto T, Shimizu E, Ishikura H, Iyo M. Immune activation during pregnancy in mice leads to dopaminergic hyperfunction and cognitive impairment in the offspring: a neurodevelopmental animal model of schizophrenia. Biol. Psychiatry. 2006;59:546–554
  31. Perry EK, Lee ML, Martin-Ruiz CM, Court JA, Volsen SG, Merrit J, et al. Cholinergic activity in autism: abnormalities in the cerebral cortex and basal forebrain. Am. J. Psychiatry. 2001;158:1058–1066
  32. Plioplys AV, Greaves A, Yoshida W. Anti-CNS antibodies in childhood neurologic diseases. Neuropediatrics. 1989;20:93–102
  33. Ricceri L, Moles A, Crawley J. Behavioral phenotyping of mouse models of neurodevelopmental disorders: relevant social behavior patterns across the life span. Behav. Brain Res. 2007;176:40–52
  34. Schneider T, Roman A, Basta-Kaim A, Kubera M, Budziszewska B, Schneider K, et al. Gender-specific behavioral and immunological alterations in an animal model of autism induced by prenatal exposure to valproic acid. Psychoneuroendocrinology. 2008;33:728–740
  35. Schopler E, Reichler RJ, Renner BR. In: The childhood autism rating scale (CARS): for diagnostic screening and classification of autism. New York: Irvington; 1986;p. 63
  36. Shi L, Fatemi SH, Sidwell RW, Patterson PH. Maternal influenza infection causes marked behavioral and pharmacological changes in the offspring. J. Neurosci. 2003;23:297–302
  37. Singer HS, Morris CM, Williams PN, Yoon DY, Hong JJ, Zimmerman AW. Antibrain antibodies in children with autism and their unaffected siblings. J. Neuroimmunol. 2006;178:149–155
  38. Singer HS, Morris CM, Gause CD, Gillin PK, Crawford S, Zimmerman AW. Antibodies against fetal brain in sera of mothers with autistic children. J. Neuroimmunol. 2008;194:165–172
  39. Singh VK, Warren RP, Odell JD, Warren WL, Cole P. Antibodies to myelin basic protein in children with autistic behavior. Brain Behav. Immun. 1993;7:97–103
  40. Singh VK, Warren R, Averett R, Ghaziuddin M. Circulating autoantibodies to neuronal and glial filament proteins in autism. Pediatr. Neurol. 1997;17:88–90
  41. Smith SE, Li J, Garbett K, Mirnics K, Patterson PH. Maternal immune activation alters fetal brain development through interleukin-6. J. Neurosci. 2007;27:10695–10702
  42. Swerdlow NR, Braff DL, Geyer MA. Animal models of deficient sensorimotor gating: what we know, what we think we know, and what we hope to know soon. Behav. Pharmacol. 2000;11:185–204
  43. Todd RD, Ciaranello RD. Demonstration of inter- and intraspecies differences in serotonin binding sites by antibodies from an autistic child. Proc. Natl. Acad. Sci. U. S. A. 1985;82:612–616
  44. Treit D, Fundytus M. Thigmotaxis as a test for anxiolytic activity in rats. Pharmacol. Biochem. Behav. 1988;31:959–962
  45. Trinchieri G. Interleukin-12 and the regulation of innate resistance and adaptive immunity. Nat. Rev., Immunol. 2003;3:133–146
  46. Vincent A, Deacon R, Dalton P, Salmond C, Blamire AM, Pendlebury S, et al. Maternal antibody-mediated dyslexia? Evidence for a pathogenic serum factor in a mother of two dyslexic children shown by transfer to mice using behavioural studies and magnetic resonance spectroscopy. J. Neuroimmunol. 2002;130:243–247
  47. Vincent A, Dalton P, Clover L, Palace J, Lang B. Antibodies to neuronal targets in neurological and psychiatric diseases. Ann. N. Y. Acad. Sci. 2003;992:48–55
  48. Zimmermann CW. Repertoires of natural autoantibodies against muscle tissue are independent of age or gender in normal human adults. A Western blot study. Clin. Chim. Acta. 1993;218:29–38

PII: S0165-5728(09)00105-2

doi: 10.1016/j.jneuroim.2009.03.011

Journal of Neuroimmunology
Volume 211, Issue 1 , Pages 39-48 , 25 June 2009